BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8730554)

  • 1. Treatment of childhood acute myeloid leukaemia.
    Taub JW; Ravindranath Y
    Baillieres Clin Haematol; 1996 Mar; 9(1):129-46. PubMed ID: 8730554
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group.
    Nesbit ME; Buckley JD; Feig SA; Anderson JR; Lampkin B; Bernstein ID; Kim TH; Piomelli S; Kersey JH; Coccia PF
    J Clin Oncol; 1994 Jan; 12(1):127-35. PubMed ID: 8270968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of acute leukaemia.
    Burnett AK; Eden OB
    Lancet; 1997 Jan; 349(9047):270-5. PubMed ID: 9014927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute leukemia.
    Lechner K; Geissler K; Jäger U; Greinix H; Kalhs P
    Ann Oncol; 1999; 10 Suppl 6():45-51. PubMed ID: 10676552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Principles of relapse therapy in acute myeloid leukemia].
    Hiddemann W; Büchner T; van de Loo J
    Dtsch Med Wochenschr; 1989 Apr; 114(15):599-605. PubMed ID: 2649351
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful induction of molecular remission with single-agent anti-CD33 antibody (gemtuzumab ozogamicin) in chemotherapy-refractory relapse of acute myeloid leukaemia post-BMT.
    Swords R; Hayden PJ; Molloy K; Lawlor M; Browne PV; Murphy PT
    Eur J Haematol; 2004 Dec; 73(6):450-1. PubMed ID: 15522070
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.
    Burnett AK; Goldstone AH; Stevens RM; Hann IM; Rees JK; Gray RG; Wheatley K
    Lancet; 1998 Mar; 351(9104):700-8. PubMed ID: 9504514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML).
    Weinstein H; Ravindranath Y; Krischer J; Steuber P; Civin C; Gresik M; Vietti T
    Leukemia; 1992; 6 Suppl 2():52-4. PubMed ID: 1578941
    [No Abstract]   [Full Text] [Related]  

  • 10. Value of maintenance therapy with chemotherapy or interferon during remission of acute myeloid leukaemia.
    Palva IP; Almqvist A; Elonen E; Hänninen A; Jouppila J; Järventie G; Koivunen E; Kätkä K; Lahtinen R; Oivanen T
    Eur J Haematol; 1991 Sep; 47(3):229-33. PubMed ID: 1915807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current options in the management of acute myeloid leukaemia.
    Kelsey SM; Newland AC
    QJM; 1995 Dec; 88(12):849-52. PubMed ID: 8593544
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis and treatment of acute myelogenous leukemia in childhood.
    Creutzig U
    Crit Rev Oncol Hematol; 1996 Apr; 22(3):183-96. PubMed ID: 8793274
    [No Abstract]   [Full Text] [Related]  

  • 13. Uterine infiltration as first sign of acute myeloid leukemia.
    Matthes T; Collao C; Samii K; Chapuis B; Girardet C; Diebold-Berger S
    Am J Hematol; 1999 Mar; 60(3):253-4. PubMed ID: 10072130
    [No Abstract]   [Full Text] [Related]  

  • 14. Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation.
    Sierra J; Brunet S; Grañena A; Olivé T; Bueno J; Ribera JM; Petit J; Besses C; Llorente A; Guardia R; Macía J; Rovira M; Badell I; Vela E; Díaz de Heredia C; Vivancos P; Carreras E; Feliu E; Montserrat E; Julía A; Cubells J; Rozman C; Domingo A; Ortega JJ
    J Clin Oncol; 1996 Apr; 14(4):1353-63. PubMed ID: 8648394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult acute myeloid leukaemia: update on treatment.
    Bishop JF
    Med J Aust; 1999 Jan; 170(1):39-43. PubMed ID: 10026673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idarubicin, high-dose cytarabine and etoposide for remission induction in therapy-related acute myeloid leukemia.
    Philpott N; Mehta J; Treleaven J; Powles R
    Leuk Lymphoma; 1994 Sep; 15(1-2):127-30. PubMed ID: 7858489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.
    Stevens RF; Hann IM; Wheatley K; Gray RG
    Br J Haematol; 1998 Apr; 101(1):130-40. PubMed ID: 9576193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party.
    Webb DK; Wheatley K; Harrison G; Stevens RF; Hann IM
    Leukemia; 1999 Jan; 13(1):25-31. PubMed ID: 10049056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
    Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ;
    Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
    Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
    Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.